Evolent Health (EVH) Payables (2015 - 2026)

Evolent Health's Payables history runs 12 years deep, the most recent figure standing at $63.0 million for Q1 2026.

• On a quarterly basis, Payables fell 72.56% year-over-year to $63.0 million in Q1 2026; TTM through Mar 2026 was $63.0 million, a 72.56% decrease from a year earlier, with the FY2025 full-year figure at $59.8 million, down 77.65% from the prior year.
• Payables improved to $63.0 million in Q1 2026 per EVH's latest filing, from $59.8 million in the prior quarter.
• Across five years, Payables topped out at $267.5 million in Q4 2024 and bottomed at $39.0 million in Q2 2024.
• The 5-year median for Payables is $63.0 million (2026), against an average of $94.9 million.
• Biggest YoY gain for Payables was 518.96% in 2025; the steepest drop was 77.65% in 2025.
• Year by year, Payables stood at $57.2 million in 2022, then declined by 15.62% to $48.2 million in 2023, then jumped by 454.43% to $267.5 million in 2024, then tumbled by 77.65% to $59.8 million in 2025, then gained by 5.41% to $63.0 million in 2026.
• Per Business Quant, the three latest EVH Payables figures stand at $63.0 million (Q1 2026), $59.8 million (Q4 2025), and $77.3 million (Q3 2025).